Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammationChi Kin Wong, Daniel J. Drucker, Brent A. McLean et al.|Cell Metabolism|2023Cited by 251
Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammationChi Kin Wong, Daniel J. Drucker, Randy J. Seeley et al.|Cell Metabolism|2022Cited by 121
Activation of Glucagon-Like Peptide-1 Receptor Signaling Does Not Modify the Growth or Apoptosis of Human Pancreatic Cancer CellsJacqueline A. Koehler, Daniel J. Drucker|Diabetes|2006Cited by 61
Glucagon-Like Peptide-1 Receptor Agonists Increase Pancreatic Mass by Induction of Protein SynthesisJacqueline A. Koehler, Daniel J. Drucker|Diabetes|2014Cited by 60
Glucagon-like Peptide-2 Does Not Modify the Growth or Survival of Murine or Human Intestinal Tumor CellsJacqueline A. Koehler, Daniel J. Drucker|Cancer Research|2008Cited by 52